Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Horizon Pharma Ord (HZNP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,537,077
  • Shares Outstanding, K 184,434
  • Annual Sales, $ 1,208 M
  • Annual Income, $ -74,190 K
  • 60-Month Beta 1.14
  • Price/Sales 3.91
  • Price/Cash Flow 6.48
  • Price/Book 4.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.10
  • Number of Estimates 5
  • High Estimate 0.15
  • Low Estimate 0.06
  • Prior Year 0.03
  • Growth Rate Est. (year over year) +233.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.12 +3.32%
on 04/18/19
28.75 -13.32%
on 03/19/19
-2.74 (-9.91%)
since 03/18/19
3-Month
20.05 +24.29%
on 02/27/19
29.44 -15.35%
on 02/28/19
+3.08 (+14.10%)
since 01/18/19
52-Week
12.55 +98.57%
on 05/09/18
29.44 -15.35%
on 02/28/19
+10.93 (+78.13%)
since 04/18/18

Most Recent Stories

More News
Principia Biopharma Appoints Shao-Lee Lin, M.D., Ph.D. to Board of Directors

Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with significant unmet medical needs in immunology and oncology,...

PRNB : 29.64 (+2.17%)
HZNP : 24.92 (+1.30%)
GILD : 62.95 (-0.47%)
Horizon Pharma plc and Gift of Adoption Announce a New Fund to Facilitate Global Adoptions of Children with Rare Diseases

Horizon Pharma plc (Nasdaq: HZNP) in partnership with Gift of Adoption today announced the creation of the #RAREis Adoption Fund to help facilitate global adoptions of children with rare...

HZNP : 24.92 (+1.30%)
Watch for Horizon Pharma P to Potentially Rebound After Falling 1.04% Yesterday

Horizon Pharma P (NASDAQ:HZNP) traded in a range yesterday that spanned from a low of $25.73 to a high of $26.24. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of...

HZNP : 24.92 (+1.30%)
Horizon Pharma plc to Present Results from its Phase 3 Teprotumumab Trial (OPTIC)at the 2019 American Association of Clinical Endocrinologists (AACE) Scientific and Clinical Congress

Horizon Pharma plc (Nasdaq: HZNP) today announced that it will present additional results from its Phase 3 confirmatory clinical trial (OPTIC) evaluating teprotumumab for the treatment of...

HZNP : 24.92 (+1.30%)
Horizon Pharma plc Named One of the 2019 Best Workplaces in Health Care and Biopharma by FORTUNE and Great Place to Work(R)

Horizon Pharma plc(NASDAQ:HZNP) today announced it has been selected as one of the 2019 Best Workplaces in Health Care and Biopharma byGreat Place to Work(R) andFORTUNE Magazine. The...

HZNP : 24.92 (+1.30%)
Why the Earnings Surprise Streak Could Continue for Horizon Pharma (HZNP)

Horizon Pharma (HZNP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

HZNP : 24.92 (+1.30%)
Shares of Eli Lilly & Co Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (LLY , HZNP , DERM , MRK , LCI )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

DERM : 11.55 (+3.77%)
HZNP : 24.92 (+1.30%)
LLY : 115.20 (-1.12%)
Horizon Pharma plc to Release First-Quarter 2019 Financial Results and Host Webcast on May 8, 2019

Horizon Pharma plc (Nasdaq: HZNP) announced today that its first-quarter 2019 financial results will be released on Wednesday, May 8, 2019. Following the announcement, Horizon's management...

HZNP : 24.92 (+1.30%)
SmarTrend Watching for Potential Rebound in Shares of Horizon Pharma P After 2.62% Loss

Horizon Pharma P (NASDAQ:HZNP) traded in a range yesterday that spanned from a low of $26.73 to a high of $26.91. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of...

HZNP : 24.92 (+1.30%)
Horizon Pharma plc Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Horizon Pharma plc (Nasdaq: HZNP) today announced that the compensation committee of its board of directors approved the grant on April 1, 2019 of inducement restricted stock units for an...

HZNP : 24.92 (+1.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade HZNP with:

Business Summary

Horizon Pharma plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs. The company markets a portfolio of products in arthritis, inflammation and orphan diseases....

See More

Key Turning Points

2nd Resistance Point 25.64
1st Resistance Point 25.28
Last Price 24.92
1st Support Level 24.34
2nd Support Level 23.76

See More

52-Week High 29.44
Last Price 24.92
Fibonacci 61.8% 22.99
Fibonacci 50% 21.00
Fibonacci 38.2% 19.00
52-Week Low 12.55

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar